These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 36925927)

  • 1. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
    Liu H; Tang T
    Front Oncol; 2022; 12():952290. PubMed ID: 36276096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer profiles of the cuproptosis gene set.
    Liu H
    Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
    Zhou C; Li C; Zheng Y; Huang X
    Front Oncol; 2022; 12():934076. PubMed ID: 36387247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer.
    AmeliMojarad M; AmeliMojarad M; Shariati P
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; ():. PubMed ID: 39120719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration.
    Chen X; Li K; Xiao Y; Wu W; Lin H; Qing X; Tian S; Liu S; Feng S; Wang B; Shao Z; Peng Y
    Biofactors; 2024 Apr; ():. PubMed ID: 38599595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics pan-cancer study of cuproptosis core gene
    Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
    Front Immunol; 2022; 13():981764. PubMed ID: 36605188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
    Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
    Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
    Zhao R; Sukocheva O; Tse E; Neganova M; Aleksandrova Y; Zheng Y; Gu H; Zhao D; Madhunapantula SV; Zhu X; Liu J; Fan R
    Cell Commun Signal; 2024 Jul; 22(1):379. PubMed ID: 39068453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
    Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
    Front Genet; 2022; 13():939956. PubMed ID: 36105090
    [No Abstract]   [Full Text] [Related]  

  • 12. Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis.
    Li G; Peng L; Wu M; Zhao Y; Cheng Z; Li G
    Front Immunol; 2022; 13():1039510. PubMed ID: 36601107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics-based dynamics of cuproptosis -related indicators in experimental silicosis.
    Xia J; Wu C; Jin X; Ding M; Zhang C; Hou G; Hao C; Yao W
    Ecotoxicol Environ Saf; 2024 Apr; 275():116286. PubMed ID: 38564864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
    Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
    Wang X; Chen X; Xu C; Zhou W; Wu D
    Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
    Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
    Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer.
    Jin L; Mei W; Liu X; Sun X; Xin S; Zhou Z; Zhang J; Zhang B; Chen P; Cai M; Ye L
    Front Immunol; 2022; 13():974034. PubMed ID: 36203594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.